Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases

Clinical trial NCT06417398 · UNKNOWN

Trial details

NCT number: NCT06417398
Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus Idiopathic Inflammatory Myopathies Systemic Sclerosis Sjogren's Syndrome Rheumatoid Arthritis Immune Thrombocytopenia Primary Biliary Cholangitis

Start date: 2024-05-14
Primary completion: 2024-12-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.